Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea

Cutis

Volumn 77, Issue 4 SUPPL., 2006, Pages 3-11

  Wolf Jr , John E ^a,b   Kerrouche, Nabil ^b   Arsonnaud, Stephanie ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID; METRONIDAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; GEL; HOSPITALIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATIENT SATISFACTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GELS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; ROSACEA; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; UNITED STATES;

EID: 33646561553     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3:489-496.
2. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother. 2004;5: 5-13.
3. Buechner SA. Rosacea: an update. Dermatology. 2005;210:100-108.
4. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol. 2005;19: 273-285.
5. Bikowski JB. The pharmacologic therapy of rosacea: a paradigm shift in progress. Cutis. 2005;75(suppl 3):27-32.
6. Wolf JE Jr. Present and future rosacea therapy. Cutis. 2005;75(suppl 3):4-7.
7. Nybaek H, Jemec GB. Photodynamic therapy in the treatment of rosacea. Dermatology. 2005;211:135-138.
8. Lehmann P. Rosacea. clinical features, pathogenesis and therapy [in German]. Hautarzt. 2005;56:871-885.
9. Gupta AK, Chaudhry M. Topical metronidazole for rosacea. Skin Therapy Lett. 2002;7:1-3, 6.
10. Wolf JE Jr. The role of topical metronidazole in the treatment of rosacea. Cutis. 2004;73(suppl 1):19-28.
11. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 1987;21:346-351.
12. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987;123:609-614.
13. Espagne E, Guillaume JC, Archimbaud A, et al. Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea. Ann Dermatol Venereol. 1993;120:129-133.
14. Breneman D, Bucko A, Friedman D, et al. Evaluation of topical metronidazole lotion in rosacea. In: Abstracts of the American Academy of Dermatology 56th Annual Meeting; February 27-March 4, 1998; Orlando, Florida. P289.
15. Drake L, Leyden J, Lucky A, et al. Evaluation of topical metronidazole cream in rosacea. In: Abstracts of the American Academy of Dermatology 55th Annual Meeting; March 21-26, 1997; San Francisco, California. P65.
16. Bitar A, Bourgouin J, Dore N, et al. A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea: a placebo-controlled study. Drug Invest. 1990;2:242-248.
17. Bjerke JR, Nyfors A, Austad J, et al. Metronidazole (Elyzol) 1% cream v. placebo cream in the treatment of rosacea. Clin Trials J. 1989;26:187-194.
18. Breneman DL, Stewart D, Hevia O, et al. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61:44-47.
19. Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol 1998;39:502-504.
20. Nielson PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63-65.
21. Odom RB. The subtypes of rosacea: implications for treatment. Cutis. 2004;73(suppl 1):9-14.
22. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45:723-730.
23. Jones D. Reactive oxygen species and rosacea. Cutis. 2004;74(suppl 3):17-20.
24. Wagner N, Berthaud C, Laffet G, et al. Differential penetration of skin by topical metronidazole formulations. Adv Ther. 1998;15:197-205.
25. Bikowski JB, Goldman MP. Rosacea: where are we now? J Drugs Dermatol 2004;3:251-261.
26. Akamatsu H, Komura J, Asada Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283:162-166.
27. Passi S, Picardo M, Zompetta C, et al. The oxyradical-scavenging activity of azelaic acid in biological systems. Free Radic Res Commun. 1991;15:17-28.
28. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 2003;139:1444-1450.